Labcorp Holdings Inc reports results for the quarter ended in September 30 - Earnings Summary

Reuters

2024-10-25

* Labcorp Holdings Inc reported quarterly adjusted earnings of $3.50 per share for the quarter ended September 30, higher than the same quarter last year, when the company reported EPS of $3.38. The mean expectation of seventeen analysts for the quarter was for earnings of $3.48 per share. Wall Street expected results to range from $3.31 to $3.65 per share.

* Revenue rose 7.4% to $3.28 billion from a year ago; analysts expected $3.26 billion.

* Labcorp Holdings Inc's reported EPS for the quarter was $2.00.

* The company reported quarterly net income of $169.3 million.

* Labcorp Holdings Inc shares had fallen by 1.6% this quarter and lost 3.3% so far this year.

FORECAST CHANGES

* The mean earnings estimate of analysts had fallen by about 6.9% in the last three months.

* In the last 30 days, three analysts negatively revised earnings estimates

RECOMMENDATIONS

* The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 13 "strong buy" or "buy," 6 "hold" and no "sell" or "strong sell."

* The average consensus recommendation for the healthcare facilities & services peer group is also "buy"

Wall Street's median 12-month price target for Labcorp Holdings Inc is 259.00 This summary was machine generated from LSEG data October 24 at 04:25 p.m. UTC. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,

MISSED

Sep. 30 2024 3.48 3.50 Beat

Jun. 30 2024 3.78 3.94 Beat

Mar. 31 2024 3.48 3.68 Beat

Dec. 31 2023 3.26 3.30 Beat

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/2478525086"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2478525086\",edition:\"fundamental\",,,undefined,":{"share":"https://ttm.financial/m/news/2478525086?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-10-25 00:25","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2478525086","market":"us","top_or_hot":-1,"title":"Labcorp Holdings Inc reports results for the quarter ended in September 30 - Earnings Summary","media":"Reuters","content":"<html><body><p>* Labcorp Holdings Inc    reported quarterly adjusted earnings of $3.50 per share for the quarter ended September 30, higher than the same quarter last year, when the company reported EPS of $3.38.  The mean expectation of seventeen analysts for the quarter was for earnings of $3.48 per share. Wall Street expected results to range from $3.31  to $3.65 per share.</p><p>   * Revenue rose 7.4% to $3.28 billion from a year ago; analysts expected $3.26 billion. </p><p>   * Labcorp Holdings Inc's reported EPS for the quarter was $2.00.</p><p>   * The company reported quarterly net income of $169.3 million.</p><p>   * Labcorp Holdings Inc shares had fallen by 1.6% this quarter and lost 3.3% so far this year.</p><p>FORECAST CHANGES</p><p>   * The mean earnings estimate of analysts had fallen by about 6.9% in the last three months. </p><p>   * In the last 30 days, three analysts negatively revised earnings estimates</p><p>RECOMMENDATIONS</p><p>   * The current average analyst rating on the shares is \"buy\" and the breakdown of recommendations is 13 \"strong buy\" or \"buy,\" 6 \"hold\" and no \"sell\" or \"strong sell.\" </p><p>   * The average consensus recommendation for the healthcare facilities & services peer group is also \"buy\"</p><p>Wall Street's median 12-month price target for Labcorp Holdings Inc is 259.00  This summary was machine generated from LSEG data October 24 at 04:25 p.m. UTC. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,</p><p>                                                MISSED</p><p>Sep. 30 2024      3.48           3.50           Beat</p><p>Jun. 30 2024      3.78           3.94           Beat</p><p>Mar. 31 2024      3.48           3.68           Beat</p><p>Dec. 31 2023      3.26           3.30           Beat</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n<meta content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\" name=\"viewport\"/>\n<meta content=\"telephone=no,email=no,address=no\" name=\"format-detection\"/>\n<title>Labcorp Holdings Inc reports results for the quarter ended in September 30 - Earnings Summary</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nLabcorp Holdings Inc reports results for the quarter ended in September 30 - Earnings Summary\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time smaller\">2024-10-25 00:25</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>* Labcorp Holdings Inc    reported quarterly adjusted earnings of $3.50 per share for the quarter ended September 30, higher than the same quarter last year, when the company reported EPS of $3.38.  The mean expectation of seventeen analysts for the quarter was for earnings of $3.48 per share. Wall Street expected results to range from $3.31  to $3.65 per share.</p><p>   * Revenue rose 7.4% to $3.28 billion from a year ago; analysts expected $3.26 billion. </p><p>   * Labcorp Holdings Inc's reported EPS for the quarter was $2.00.</p><p>   * The company reported quarterly net income of $169.3 million.</p><p>   * Labcorp Holdings Inc shares had fallen by 1.6% this quarter and lost 3.3% so far this year.</p><p>FORECAST CHANGES</p><p>   * The mean earnings estimate of analysts had fallen by about 6.9% in the last three months. </p><p>   * In the last 30 days, three analysts negatively revised earnings estimates</p><p>RECOMMENDATIONS</p><p>   * The current average analyst rating on the shares is \"buy\" and the breakdown of recommendations is 13 \"strong buy\" or \"buy,\" 6 \"hold\" and no \"sell\" or \"strong sell.\" </p><p>   * The average consensus recommendation for the healthcare facilities & services peer group is also \"buy\"</p><p>Wall Street's median 12-month price target for Labcorp Holdings Inc is 259.00  This summary was machine generated from LSEG data October 24 at 04:25 p.m. UTC. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,</p><p>                                                MISSED</p><p>Sep. 30 2024      3.48           3.50           Beat</p><p>Jun. 30 2024      3.78           3.94           Beat</p><p>Mar. 31 2024      3.48           3.68           Beat</p><p>Dec. 31 2023      3.26           3.30           Beat</p>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LH","symbol_name":"徠博科","start_time":0,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","article_id":"2478525086","we_media_id":"1036604489","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2478525086","pubTimestamp":1729787157,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"summary":"* Labcorp Holdings Inc    reported quarterly adjusted earnings of $3.50 per share for the quarter ended September 30, higher than the same quarter last year, when the company reported EPS of $3.38.  T","collect":0,"end_time":0,"defaultTopTitle":"","property":["earning"],"viewcount":null,"language":"en","relate_stocks":{"LH":"徕博科"},"translate_title":"Labcorp Holdings Inc报告截至9月30日的季度业绩-收益摘要","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"LH":1},"content_text":"* Labcorp Holdings Inc    reported quarterly adjusted earnings of $3.50 per share for the quarter ended September 30, higher than the same quarter last year, when the company reported EPS of $3.38.  The mean expectation of seventeen analysts for the quarter was for earnings of $3.48 per share. Wall Street expected results to range from $3.31  to $3.65 per share.   * Revenue rose 7.4% to $3.28 billion from a year ago; analysts expected $3.26 billion.    * Labcorp Holdings Inc's reported EPS for the quarter was $2.00.   * The company reported quarterly net income of $169.3 million.   * Labcorp Holdings Inc shares had fallen by 1.6% this quarter and lost 3.3% so far this year.FORECAST CHANGES   * The mean earnings estimate of analysts had fallen by about 6.9% in the last three months.    * In the last 30 days, three analysts negatively revised earnings estimatesRECOMMENDATIONS   * The current average analyst rating on the shares is \"buy\" and the breakdown of recommendations is 13 \"strong buy\" or \"buy,\" 6 \"hold\" and no \"sell\" or \"strong sell.\"    * The average consensus recommendation for the healthcare facilities & services peer group is also \"buy\"Wall Street's median 12-month price target for Labcorp Holdings Inc is 259.00  This summary was machine generated from LSEG data October 24 at 04:25 p.m. UTC. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,                                                MISSEDSep. 30 2024      3.48           3.50           BeatJun. 30 2024      3.78           3.94           BeatMar. 31 2024      3.48           3.68           BeatDec. 31 2023      3.26           3.30           Beat","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"express","news_rank":0,"symbols":[],"gpt_button":1}}}